The Evolving Endocrine Management of Metastatic Breast Cancer
At the conclusion of this presentation the participant should be able to:
1. Recognize the clinical and molecular subtypes of breast cancer.
2. Recognize the standard endocrine therapies for Estrogen-resistant metastatic breast cancer.
3. Recognize and implement novel molecular therapies in Estrogen-resistant metastatic breast cancer.
Presentation: 32 minutes
Recommended CitationCristofanilli, MD, FACP, Massimo, "The Evolving Endocrine Management of Metastatic Breast Cancer" (2014). Department of Surgery Presentations and Grand Rounds. Presentation 10.